Atomoxetine 80 mg Capsules Recalled for N-Nitroso Impurity Contamination
Glenmark Pharmaceuticals is recalling 87,600 bottles of Atomoxetine 80 mg capsules nationwide due to N-Nitroso Atomoxetine impurity detected above FDA-recommended limits. Consult your healthcare provider if affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a prescription drug with confirmed impurity contamination above regulatory limits. N-Nitroso Atomoxetine poses genotoxic and carcinogenic risks, qualifying as a risk-of-harm product where no injury has been reported, meeting the High severity threshold.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA, is recalling Atomoxetine Capsules, USP, 80 mg (30-capsule bottles) distributed nationwide. The recall affects approximately 87,600 bottles due to CGMP deviations discovered during manufacturing quality control.
The affected lots contain N-Nitroso Atomoxetine impurity at levels above FDA-recommended limits. This impurity was identified during quality control measures and prompted the Class II recall.
Patients taking Atomoxetine 80 mg should check if their medication is from one of the recalled lots, which include lot numbers 19234153 (expiring 9/2025), 19234900 and 19234929 (expiring 11/2025), 19240936 and 19240942 (expiring 2/2026), 19243199 and 19243190 (expiring 7/2026), and 19244013 and 19244014 (expiring 9/2026). Patients with affected medication should consult their healthcare provider or pharmacist for guidance on treatment.
The recalled product
- Product
- ATOMOXETINE (ATOMOXETINE)
- Brand
- ATOMOXETINE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Affected units
- 87,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot Numbers: 19234153
- Exp.: 9/2025
- 19234900
- 19234929
- Exp.: 11/2025
- 19240936
- 19240942
- Exp.: 2/2026
- 19243199
- 19243190
- Exp.:7/2026
- 19244013
- 19244014
- Exp.: 9/2026.
UPCs (7)
- 0368462265307
- 0368462270301
- 0368462267301
- 0368462271308
- 0368462268308
- 0368462269305
- 0368462266304
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same brand · ATOMOXETINE
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- HighAtomoxetine Capsules Recalled Due to Excess N-Nitroso Impurity
FDA (Drugs) · 2025-02-26
- ModerateAtomoxetine Capsules Recalled for Chemical Impurity Above FDA Limits
FDA (Drugs) · 2025-02-26
- HighAtomoxetine Capsules Recalled Due to N-Nitroso Impurity Contamination
FDA (Drugs) · 2025-02-26
- HighAtomoxetine Capsules Recalled for N-Nitroso Impurity Above FDA Limits
FDA (Drugs) · 2025-02-26
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · n nitroso impurity
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFurosemide tablets recalled for presence of N-nitroso impurity
FDA (Drugs) · 2026-04-29
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11